“The software can accurately identify a malignancy in or around the pancreas, and more expeditiously move that patient into cancer care pathways.”
Russell C. Langan, MD, FACS, FSSO, Associate Chief Surgical Officer, System Integration and Quality & Director of Surgical Oncology, RWJBarnabas
37x
increase in patients
identified
77%
Return-to-care rate for
high-risk cyst patients
(≤30% national benchmark)
55%
cancers caught at
non-metastatic stages
(higher than baselines)
RWJBarnabas Health | August 2020 - October 2025